A PYMNTS Company

Suboxone Manufacturer Must Face Antitrust Suit Brought By 42 States

By  |  August 22, 2022

A group of 42 states, led by Wisconsin, can move forward with legal action against the makers of a drug used to treat opioid dependence.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The announcement comes after a ruling by the Court in the Eastern District of Pennsylvania, saying they can proceed with a lawsuit. Wisconsin Assistant Attorney General for Antitrust Gwendolyn Lindsay Cooley is at the head of the investigation, along with states that include Illinois, Iowa and Minnesota.

    The group of states accuse Indivior Inc. of illegally shifted the market for the drug, Suboxone, from tablets to film in an attempt to eradicate the demand for tablets. It’s alleged that the company is doing this to preserve its monopoly on the drug.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.